Since these inhibitors do not induce apoptosis in other types of AML cells, targeting FLT3-ITD could selectively induce apoptosis in FLT3-ITD AML cells through GSK3β activation-mediated Mcl-1 downregulation. Here, MCL1 is linked to acute myeloid leukemia.